Equasens SA
PAR:EQS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Equasens SA
PAR:EQS
|
FR |
|
F
|
Fifth Third Bancorp
DUS:FFH
|
US |
|
A
|
Aristocrat Leisure Ltd
XMUN:AC8
|
AU |
|
A
|
AES Corp
XMUN:AES
|
US |
|
Bechtle AG
OTC:BECTY
|
DE |
|
Teleperformance SE
F:RCF0
|
FR |
Intrinsic Value
Is EQS undervalued or overvalued?
See the intrinsic value estimate for Equasens SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Equasens Does
Equasens SA is a French software and technology company focused on the healthcare sector. It builds and sells digital tools that help pharmacies, doctors, nurses, hospitals, and care facilities manage prescriptions, patient records, billing, and day-to-day administration. Its products are designed to sit inside the workflow of healthcare professionals, so the company is less of a general IT vendor and more of a specialist provider for regulated medical and pharmacy businesses.
- Headquarters
- France FR
- Employees
- 1 400
- IPO date
- Oct 20, 2000
Equasens has no economic moat
Equasens SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Equasens SA
The intrinsic value for Equasens SA (EQS) under the Base Case is hidden EUR.
Compared with the current market price of 30.05 EUR, the stock appears hidden.